Claim OwnershipASHPOfficial
Subscribed: 123Played: 7,653
Subscribe
© Copyright 2025 All rights reserved.
Description
ASHPOfficial is the premier podcast of ASHP and the collective voice of our 60,000 members in health-system pharmacy. Through interviews and discussions with pharmacy thought leaders, ASHPOfficial will explore issues related to public health, medication use, and supporting the professional practice of pharmacists in hospitals, health systems, ambulatory clinics, and other settings. To learn more about ASHP, please visit ashp.org.
1267 Episodes
Reverse
This activity will discuss clinical and safety strategies for implementation that will translate to better care for patients and a safer handling environment for providers, patients, and caregivers. Additional details and discussion about collection, processing to final dose product, dose storage/preparation/administration, and safe handling may provide more insight and considerations applicable for pharmacy practice. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode features the 2025 ASHP Best Practice Award winning team at the Veterans Administration (VA), recognized for a program focusing on pharmacist-led pharmacogenomics testing. Listeners will learn how the VA started and expanded the program including how they trained pharmacists, implemented the program, and expanded access to patient care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field on PAH.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode focuses on the challenges and strategies surrounding the cost and insurance coverage of anti-obesity medications. Guests share insights on navigating Medicare, Medicaid, and commercial insurance barriers, as well as tips for utilizing manufacturer programs, savings cards, and coding strategies to improve patient access. The discussion highlights the pharmacist’s role in helping patients overcome financial obstacles and sustain access to effective obesity treatments.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Immediate-Past Chair of the Section of Community Pharmacy Practitioners Courtney Isom sits down with the Section of Community Pharmacy Practitioners Distinguished Service Awardee Melissa Ortega to discuss what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode will cover the background of cellular-based gene therapies from basic cell biology to genetic targets currently used in treatment. Experts will review the mechanisms for modifying cellular genetic material and the common viral vector platforms used in ex-vivo cellular therapy production. An overview of the steps and processes for cellular therapy preparation, manufacturing, handling and administration will be provided. Additionally, this presentation will discuss novel cellular therapy agents currently approved for use and the highly anticipated cellular therapies currently under investigation. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast is a review of current literature and expert consensus regarding the periprocedural management of glucagon-like peptide (GLP) medications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field of Opioid REMS including appropriate treatment for pain management including opioids, non-opioid analgesics, and non-pharmacological therapies.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode will provide opportunities for the health-system pharmacist to improve understanding of in vivo and viral-based therapies on an institutional level, outline strategies for toxicity prevention and management, and provide recommendations to ensure availability of supportive care therapies to maintain patient safety, when needed. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode addresses the growing challenge of adolescent obesity, which now affects over 22% of US teens. The discussion highlights Food and Drug Administration-approved pharmacotherapy options for adolescents, considerations for side effects and monitoring, and the importance of pairing medications with lifestyle interventions. The episode also explores strategies for providing patient-centered, bias-free care and engaging families in long-term weight management.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features John Wood, Executive Medical Director, Primary Care and Population Health, Penn Medicine Lancaster General Health, and James Kelly, Regional Medical Director and Primary Care Provider, Penn Medicine Lancaster General Health, as they share their perspectives on the vital role pharmacists play in supporting patients. They discuss how pharmacists enhance care, improve outcomes, and strengthen the physician–pharmacist partnership.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
1Billing opportunities in ambulatory care can often be complicated to navigate, and annual changes in the physician fee schedule can both add opportunities and create confusion. This podcast provides an overview of the 2026 physician fee schedule as it relates to current billing practices, potential new opportunities for pharmacy billing, and other information relevant to ambulatory practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode features the 2025 ASHP Best Practice Award winning team at New York Presbyterian Hospital, recognized for their program focusing on ambulatory care pharmacist embedded in clinics improved access to patient care. Listeners will learn how ambulatory care pharmacists created a critical role in promoting equitable, patient-centered care, and how they improved care outcomes among underserved populations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Drs. Joe DiPiro and James Hoffman discuss the ASHP/ASHP Foundation 2026 Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores how the Inflation Reduction Act’s (IRA) drug price negotiation program is reshaping the relationship between CMS, drug manufacturers, and providers. We’ll explore what the proposed IRA implementation framework means for our healthcare system, highlighting the financial, legal, and transparency implications for pharmacies and patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode explores the Leader-Member Exchange (LMX) theory, offering pharmacy technicians practical strategies to strengthen relationships with leaders, advocate for their goals, and leverage networking and mentorship to advance their careers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode dives into the critical management strategies for drug-induced hyperthermia, exploring the underlying mechanisms, clinical challenges, and evidence-based interventions. Listeners will gain practical insights into recognizing early warning signs, implementing rapid cooling techniques, and optimizing pharmacologic approaches to improve patient outcomes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this podcast explores dosing conundrums specific to agents in oncology chemotherapy, antimicrobials, and therapeutic heparin use in over and underweight patients. Listeners will understand the complexity given conflicting data and receive guidance for dosing considerations to implement in clinical practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Megan Rech and Dr. Brett Faine discuss the AJHP theme issue on emergency medicine pharmacy practice with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode explores key points for establishing and adjusting anticoagulation management plans for complex patients. The episode discusses key considerations for anticoagulation management in multiple care settings, including ambulatory care and critical care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Download from Google Play
Download from App Store
United States
Wow, why did she make an internal program sound like an advertisement?
The increase of the duties and responsibilities of pharmacy technicians have quickly outpaced pay and even education in some states, therefore you have the reason for your workforce shortage. I understand the problem of pharmacies lacking monetary resources to increase pay, but something needs to change and that's not more duties.